This trial is active, not recruiting.

Conditions thyroid cancer, papillary, leptin levels
Sponsor University of Nebraska
Start date August 2012
End date June 2013
Trial size 150 participants
Trial identifier NCT01659385, 276-12-EP


The purpose of this study is to evaluate Leptin levels in females, in the setting of papillary thyroid cancer, benign thyroid nodules, and in normal females without thyroid disease.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Time perspective cross-sectional

Primary Outcomes

evaluating Leptin level Evaluating Serum Leptin Levels Between 3 Groups. One Group with Papillary Thyroid Carcinoma. One Group With Benign Nodules. One Group with Normal Thyroid.
time frame: During Study

Eligibility Criteria

Female participants from 19 years up to 75 years old.

Inclusion Criteria: - Female - Age>/- 19 - Not currently pregnant or lactating - Normal thyroid gland by history Exclusion Criteria: - Male Gender - Pregnancy - Lactation - Age below 19 - Abnormal thyroid gland by history - Abnormal thyroid gland by structure using ultrasound - Abnormal thyroid gland by function using TSH, Free T4

Additional Information

Official title Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls
Principal investigator Whitney Goldner, MD
Description There will be three groups in this study, but 2 of the groups are part of another study so will only recruit normal controls.
Trial information was received from ClinicalTrials.gov and was last updated in June 2013.
Information provided to ClinicalTrials.gov by University of Nebraska.